Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease
Western Sydney Local Health District
60 participants
Nov 3, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this randomized clinical trial is to test the efficacy of stereotactic body radiation therapy (SBRT) in treating ventricular tachycardia (VT) in patients with advanced structural heart disease. The main questions it aims to answer are: * What is the efficacy of SBRT compared to catheter ablation (CA) in achieving a ≥ 75% reduction in VT burden at 6 months * What is the comparable safety profile of SBRT vs CA Researchers will compare SBRT and CA (standard of care).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Delivery of 25Gy in a single dose fraction to target area within 6 weeks of randomization
CA (endocardial and/or epicardial at operator discretion) within 6 weeks of randomization.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06360939